Antithrombotic therapy in children

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 748S-769S

  Michelson, Alan D ^a   Bovill, Edwin ^a   Monagle, Paul ^a   Andrew, Maureen ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; REVIRAPIN; STREPTOKINASE; UNCLASSIFIED DRUG; UROKINASE; WARFARIN;

ANTICOAGULATION; BLEEDING; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONGENITAL HEART DISEASE; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MECHANISM; HEART VALVE PROSTHESIS; HEPARINIZATION; HUMAN; MONITORING; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0031761176     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5_Supplement.748S     Document Type: Conference Paper

References (9)

1. Andrew M, Marzinotto V, Brooker LA, et al. Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 1994; 71:265-269
2. Massicotte P, Marzinotto, V, Vegh P, et al. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J Pediatr 1995; 127:389-394
3. 2aMichelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest 1995; 108(suppl):506S-522S
4. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70:165-172
5. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12:95-104
6. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72:1651-1657
7. Reverdiau-Moalic P, Delahousse B, Body G, et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88:900-906
8. Hirsh J, Raschke R, Warkentin TE, et al. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety. Chest 1995; 108:2585-2755
9. Schmidt B, Ofosu FA, Mitchell L, et al. Anticoagulant effects of heparin in neonatal plasma. Pediatr Res 1989; 25:405-408